Skip to main content
. 2014 Jul 29;45(4):1372–1380. doi: 10.3892/ijo.2014.2569

Figure 8.

Figure 8

Figure 8

Hospicells protect HL60 cells against daunorubicin effect in the presence of IGF-I. HL60 was co-cultivated with Hospicells in the presence of IGF-I alone or with PPP. The chemotherapy agent, daunorubicin was added to the culture medium for 24 h (A). HL60/Dnr cells co-cultivated with Hospicells from AML N3 in the presence of IGF-I or PPP during 24 h and were incubated thereafter with daunorubicin (B). Average ± SE, (n=3), the difference in expression is significant (*P<0.05, ***P<0.0005).